Literature DB >> 34379433

Blood-Brain Barrier Crossing Renin-Angiotensin System Drugs: Considerations for Dementia and Cognitive Decline.

Lidia Glodzik1, Monica M Santisteban2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34379433      PMCID： PMC9125564          DOI： 10.1161/HYPERTENSIONAHA.121.17595

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


× No keyword cloud information.
  10 in total

Review 1.  Beneficial effects of Angiotensin II receptor blockers in brain disorders.

Authors:  J M Saavedra
Journal:  Pharmacol Res       Date:  2017-07-12       Impact factor: 7.658

2.  Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.

Authors:  Michael Ouk; Che-Yuan Wu; Jennifer S Rabin; Jodi D Edwards; Joel Ramirez; Mario Masellis; Richard H Swartz; Nathan Herrmann; Krista L Lanctôt; Sandra E Black; Walter Swardfager
Journal:  Neurobiol Aging       Date:  2020-12-16       Impact factor: 4.673

3.  Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series.

Authors:  Ihab Hajjar; Lauren Brown; Wendy J Mack; Helena Chui
Journal:  Arch Neurol       Date:  2012-12

4.  Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension.

Authors:  Monica M Santisteban; Sung Ji Ahn; Diane Lane; Giuseppe Faraco; Lidia Garcia-Bonilla; Gianfranco Racchumi; Carrie Poon; Samantha Schaeffer; Steven G Segarra; Jakob Körbelin; Josef Anrather; Costantino Iadecola
Journal:  Hypertension       Date:  2020-07-13       Impact factor: 10.190

5.  Diversity and Disparities in Dementia Diagnosis and Care: A Challenge for All of Us.

Authors:  Claudia H Kawas; María M Corrada; Rachel A Whitmer
Journal:  JAMA Neurol       Date:  2021-06-01       Impact factor: 18.302

6.  Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis.

Authors:  Lorenza Scotti; Lisette Bassi; Davide Soranna; Federico Verde; Vincenzo Silani; Antonio Torsello; Gianfranco Parati; Antonella Zambon
Journal:  Pharmacol Res       Date:  2021-02-24       Impact factor: 7.658

7.  Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.

Authors:  Lidia Glodzik; Henry Rusinek; Angela Kamer; Elizabeth Pirraglia; Wai Tsui; Lisa Mosconi; Yi Li; Pauline McHugh; John Murray; Schantel Williams; Ricardo S Osorio; Catherine Randall; Tracy Butler; Anup Deshpande; Shankar Vallabhajolusa; Mony de Leon
Journal:  Alzheimers Dement (Amst)       Date:  2016-04-19

8.  Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.

Authors:  Jean K Ho; Frank Moriarty; Jennifer J Manly; Eric B Larson; Denis A Evans; Kumar B Rajan; Elizabeth M Hudak; Lamiaa Hassan; Enwu Liu; Nobuyuki Sato; Naoyuki Hasebe; Danielle Laurin; Pierre-Hugues Carmichael; Daniel A Nation
Journal:  Hypertension       Date:  2021-06-21       Impact factor: 9.897

9.  Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.

Authors:  Daniel A Nation; Melanie D Sweeney; Axel Montagne; Abhay P Sagare; Lina M D'Orazio; Maricarmen Pachicano; Farshid Sepehrband; Amy R Nelson; David P Buennagel; Michael G Harrington; Tammie L S Benzinger; Anne M Fagan; John M Ringman; Lon S Schneider; John C Morris; Helena C Chui; Meng Law; Arthur W Toga; Berislav V Zlokovic
Journal:  Nat Med       Date:  2019-01-14       Impact factor: 53.440

10.  Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.

Authors:  Jan Willem van Dalen; Zachary A Marcum; Shelly L Gray; Douglas Barthold; Eric P Moll van Charante; Willem A van Gool; Paul K Crane; Eric B Larson; Edo Richard
Journal:  Neurology       Date:  2020-11-05       Impact factor: 9.910
  10 in total
  2 in total

Review 1.  Statins and cognition: Modifying factors and possible underlying mechanisms.

Authors:  Tahereh Jamshidnejad-Tosaramandani; Soheila Kashanian; Mohamed H Al-Sabri; Daniela Kročianová; Laura E Clemensson; Mélissa Gentreau; Helgi B Schiöth
Journal:  Front Aging Neurosci       Date:  2022-08-15       Impact factor: 5.702

Review 2.  Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.

Authors:  Lucía A Méndez-García; Galileo Escobedo; Alan Gerardo Minguer-Uribe; Rebeca Viurcos-Sanabria; José A Aguayo-Guerrero; José Damián Carrillo-Ruiz; Helena Solleiro-Villavicencio
Journal:  Front Cell Neurosci       Date:  2022-09-16       Impact factor: 6.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.